Worldwide, the age of COVID-19 has ushered in a plethora of medical claims concerning the use of natural products to prevent and/or treat the pathogen.
Here in the U.S., the Federal Trade Commission (FTC) has been clamping down on bad actors, and those well-intentioned but under-informed about the current, and sometimes opaque, rules of the road.
Federal responses have been accelerated by a perniciously persistent pandemic that lacks an approved drug-based prophylactic therapy, a vaccine, or treatment, other than one repurposed COVID-19 treatment therapy, Remdesivir.
We are all in pursuit of reasonable solutions to prevent, manage, and overcome this virus. Traditional therapies across cultures and provider disciplines are being explored and observed clinically, if not studied in large randomized placebo-controlled trials.
The leadership of The American Association of Naturopathic Physicians (AANP), in coordination with integrative health professionals, dietary supplement manufacturers, and longtime industry attorney Alan Dumoff, has created an important and prescient Fact Sheet on Regulatory Agency Warning Letters During COVID-19 Pandemic.
“Any discussion of COVID-19 mitigation, prevention or cure using dietary ingredients or herbs, connected to the sale of those products, is a direct violation of the prohibition against disease claims for dietary supplements.” ~AANP Fact Sheet on Regulatory Agency Warning Letters During COVID-19 Pandemic